Schultz kept Teva away from the abyss, but couldn't find a runway to growth | Ctech
Teva paid top executives $330m while share price tanked - Globes
Teva CEO steps down, replacement found — MedWatch
Kåre Schultz lands first chairmanship following Teva exit — MedWatch
Teva Pharmaceuticals on X: "Speaking at #JPM2020, Teva CEO Kåre Schultz discussed the company's restructuring, future growth drivers, and a focus on the needs of patients and customers. Listen to a replay
Teva Pharmaceuticals on LinkedIn: Richard Francis, Teva Pharmaceuticals President & CEO, appeared on…
Teva names Richard Francis to replace CEO Schultz - Medical Buyer
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO | Reuters
Israel's Teva Pharm to start paying US opioid settlement in 2023 -CEO - The Jerusalem Post
Teva CEO Richard Francis, after 120 days at the helm, preps grand strategic reveal
Teva CEO Richard Francis on Q2 earnings beat - YouTube
Teva CEO says production and distribution in Israel remain largely unaffected by war | The Times of Israel
Teva CEO on Advancing Health Care | BCG
New Teva CEO reorganizes with an 'ax, not hedge clippers or pruning shears' - STAT
Teva Names Interim CEO, New Chairman As Vigodman Steps Down
Watch Teva CEO on Second-Quarter, Potential DOJ Settlement - Bloomberg
Teva Loses CEO, Leaving Investors to Guess What's Next - Bloomberg
Teva CEO Erez Vigodman Steps Down | CHEManager
Teva has made short work of its hunt for a new CEO
Teva Pharmaceuticals on LinkedIn: #jpm #jpm2024 #tevapharm #fiercejpmweek #fiercebiotech #fiercepharma…
Kåre Schultz Teva Pharmaceuticals CEO Rating | Comparably
Richard Francis - Teva Pharmaceuticals | LinkedIn
Where is Kåre Schultz? | Ctech
Teva to depend on innovation as it seeks end to revenue slide
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
